Advertisement

Topics

FDA fast tracks Valneva's Lyme disease vaccine

04:35 EDT 7 Aug 2017 | Pharmafile

French firm Valneva has announced that its Lyme disease vaccine, known at this stage only by VLA15, has been fast-tracked for approval by the FDA. There is no vaccine available to prevent Lyme disease infection in humans, though one is available for dogs.

read more

Original Article: FDA fast tracks Valneva's Lyme disease vaccine

NEXT ARTICLE

More From BioPortfolio on "FDA fast tracks Valneva's Lyme disease vaccine"

Quick Search
Advertisement
 

Relevant Topic

Vaccine
A vaccine is a biological preparation that improves immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism, and is often made from weakened or killed forms of the microbe, its toxins or one ...